The Pharma Data

JUNE 29, 2021

New Soliqua ® * data shows improved blood sugar control without weight gain versus premixed insulin. Study also shows more people on Soliqua had improved blood sugar control without weight gain and without low blood sugar events (hypoglycemia) in first head-to-head comparison with premixed insulin.

Insulin 52

Insulin Medicine Compliance Marketing 52

Pharmaceutical Technology

DECEMBER 15, 2022

With many classes of antimicrobial agents on the market, it can be difficult to choose the right one for a new formulation. In addition, several pieces of documentation will be required to support the API qualification, e.g. pharmacopeial compliance. Full compliance to both monographs and general notices and chapters is recommended.

Insulin 130

Insulin Production Compliance Manufacturing 130

Roots Analysis

AUGUST 1, 2024

GLP-1 receptor agonist market have captured the attention of both large and small pharmaceutical companies, for more than a decade. GLP-1 Receptor Agonist Market – Current Landscape Presently, more than 150 GLP-1 drug candidates have been commercialized / being developed by more 55 developers to treat various metabolic disorders.

Marketing 52

Marketing Insulin Drugs Development 52

XTalks

JULY 15, 2021

However, as a needle-free test, the saliva test offers a painless and non-invasive way to monitor sugar levels, which could significantly help with compliance. Related: Droplet Micron Insulin Needle Offers Innovation in Crowded Diabetes Supply Market. Over 460 million people around the world live with diabetes.

Development 98

Development Research Containment Manufacturing 98

FDA Law Blog

JANUARY 5, 2023

Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. Post-market, combination products potentially face the same enforcement scrutiny as single-entity medical devices. By John W.M.

Regulation 59

Regulation Production Drug Delivery Marketing 59

Roots Analysis

FEBRUARY 22, 2022

One of the most widely recognized autoinjector in the market is EpiPen® (Mylan), which is a prefilled epinephrine autoinjector. The market landscape is predominantly characterized by the presence of several small and mid-sized companies with a few established players. The generic version of EpiPen received the FDA approval in 2018.

Drug Delivery 52

Drug Delivery Production Marketing Development 52

Roots Analysis

SEPTEMBER 18, 2023

Improved patient compliance : With reduced injection frequency and simplified administration, these large volume wearable injectors can lead to better patient adherence to prescribed treatments. Patients are more likely to comply with their medication schedules when the process is less cumbersome and requires fewer interactions.

Drug Delivery 52

Drug Delivery Drugs Compliance Marketing 52

XTalks

JUNE 12, 2023

Medtronic’s Hugo Robotic-Assisted Surgery system , released in a limited market in June 2021, has been receiving positive reviews for its performance in various surgeries. Internationally, Medtronic expanded its MiniMed 780G insulin pump and Guardian 4 sensor. It also plans to launch these products in the US. percent from $27.06

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

Pharmaceutical Technology

MAY 17, 2023

It is no exaggeration to say that the world changed in the early 80s when insulin was expressed synthetically in microorganisms for the first time. This breakthrough led to a recombinant (biosynthetic) and thereby safer therapy for diabetes than the animal-sourced insulin which had been used since 1922.

Insulin 130

Insulin Production Manufacturing Contamination 130

The Pharma Data

NOVEMBER 30, 2020

The simplification transaction will reduce the Company’s tax compliance costs, enhance its ability to structure future acquisitions and result in the Class A Common Stock being the Company’s only class of Common Stock outstanding.

Containment 40

Containment Compliance Production Manufacturing 40

FDA Law Blog

DECEMBER 3, 2023

covered insulin product or vaccine). Each phase-in program requires the manufacturer to have had a Coverage Gap Discount Program agreement in effect in 2021, and only covers applicable drugs that have been in the market as of August 16, 2022 (i.e., Audits and Compliance Monitoring: Using its discretionary authority under 42 U.S.C.

Manufacturing 105

Manufacturing Drugs Compliance Pharmacy 105

Roots Analysis

SEPTEMBER 22, 2023

These significant benefits offered by wearable injectors, coupled with their rising demand in the pharmaceutical industry and healthcare sector, worldwide is likely to drive market growth during in the coming years. If the USFDA finds the product to be unsafe and ineffective, it may not get marketing approval.

Drug Delivery 40

Drug Delivery Marketing Insulin Drugs 40

The Pharma Data

AUGUST 3, 2021

. – Second-quarter 2021 operating expenses increased 18 percent, driven primarily by higher research and development investments for late-stage assets, as well as higher relative marketing and selling expenses due to pandemic-related spending reductions in 2020. – Second-quarter 2021 earnings per share (EPS) decreased to $1.53

Antibody 52

Antibody Sales Development Production 52

pharmaphorum

JUNE 10, 2021

The fundamental misconception among the public, the media and even some lawmakers is that higher drug list prices are the result of drug manufacturers being in a monopolistic position to endlessly raise prices on critical drugs like insulin and then rake in big profits. About the author. Jesse Mendelsohn is vice president at Model N.

Manufacturing 105

Manufacturing Drugs Pharma Companies Pharmacy 105

The Pharma Data

MAY 14, 2021

It may also improve your sensitivity to insulin, which means it works better in your body. Talk to your doctor about whether you need to adjust your meds or insulin dose to keep your levels high enough. Jonathan Garner is a pen name used for marketing purposes and to protect the author’s identity. Eat a Well-Balanced Diet.

Production 52

Production Packaging Packaging Insulin 52

Pharma Marketing Network

APRIL 21, 2025

Enter email marketing campaigns a digital tactic that’s proving to be more than just effective. But are these campaigns truly worth the investment in 2025’s competitive and compliance-heavy landscape? However, in 2025, the digital transformation continues to accelerate.

Marketing 52

Marketing Branding Compliance Pharma Companies 52

Roots Analysis

JANUARY 27, 2025

Within microbial fermentation market, service providers presently claim to have most of the microbial production capacity, driving innovators to outsource their manufacturing needs and shift their focus on research and development efforts. Key Trends in the Microbial CMO Market A. Key Growth Drivers 1.

Marketing 40

Marketing Manufacturing Production Development 40